what mutation causes factor v leiden glutathione - an overview Factor V Leiden is an

DHODH is significantly downregulated at the mRNA level in response to 5FU treatment (RNA sequencing (RNA-seq) data

Western medications currently used clinically to treat osteoporosis include bone formation enhancers, bisphosphonates, denosumab, receptor activator inhibitors, selective oestrogen receptor modulators and hormone replacement therapies, as suggested by international guidelines including the 2022 Hormone Therapy Position Statement of The North American Menopause Society for the primary prevention of bone loss as well as the dual-action drug sclerostin monoclonal antibody [11, 12] Although these medications may increase bone density and reduce the risk of fractures in patients, they are still associated with common adverse effects [11, 12] including gastrointestinal symptoms, osteonecrosis of the jaw, atypical femoral fractures and increased cardiovascular risks with prolonged use

doi: 10.4172/2157-7439.1000265 424 JiaMZhangWHeTShuMDengJWangJet al

10.1038/nature13909 10 DangY.HeQ.YangS.SunH.LiuY.LiW.et al (2022)